(Q30230272)

11 June 2017

1 reference

title

Progress towards the treatment of Ebola haemorrhagic fever (English)

1 reference

11 June 2017

main subject

Ebola hemorrhagic fever

0 references

Orthoebolavirus zairense

0 references

2

Heinz Feldmann

1 reference

11 June 2017

1

Ute Ströher

1 reference

11 June 2017

language of work or name

English

0 references

publication date

1 December 2006

1 reference

Expert Opinion on Investigational Drugs

11 June 2017

published in

1 reference

11 June 2017

volume

15

1 reference

11 June 2017

issue

12

1 reference

11 June 2017

page(s)

1523-1535

1 reference

Ebola virus: from discovery to vaccine

11 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Fruit bats as reservoirs of Ebola virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Experimental inoculation of plants and animals with Ebola virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Emerging and re-emerging infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Hemorrhagic fever viruses as biological weapons: medical and public health management

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

A serological survey of Ebola virus infection in central African nonhuman primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Catastrophic ape decline in western equatorial Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

The role of DC-SIGN and DC-SIGNR in HIV and Ebola virus infection: can potential therapeutics block virus transmission and dissemination?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Folate receptor-alpha is a cofactor for cellular entry by Marburg and Ebola viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Folate receptor alpha and caveolae are not required for Ebola virus glycoprotein-mediated viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Processing of the Ebola virus glycoprotein by the proprotein convertase furin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Ebola virus VP40 drives the formation of virus-like filamentous particles along with GP

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Filovirus assembly and budding

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Vesicular release of ebola virus matrix protein VP40.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Infection of naive target cells with virus-like particles: implications for the function of ebola virus VP24.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

The nonstructural small glycoprotein sGP of Ebola virus is secreted as an antiparallel-orientated homodimer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Delta-peptide is the carboxy-terminal cleavage fragment of the nonstructural small glycoprotein sGP of Ebola virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

An introduction to Ebola: the virus and the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Ebola virus: the role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Proinflammatory response during Ebola virus infection of primate models: possible involvement of the tumor necrosis factor receptor superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Apoptosis induced in vitro and in vivo during infection by Ebola and Marburg viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Association of Ebola-related Reston virus particles and antigen with tissue lesions of monkeys imported to the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Infection and activation of monocytes by Marburg and Ebola viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Ebola and Marburg viruses replicate in monocyte-derived dendritic cells without inducing the production of cytokines and full maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Ebola and Marburg virus-like particles activate human myeloid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Protection from lethal infection is determined by innate immune responses in a mouse model of Ebola virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

The Ebola virus VP35 protein functions as a type I IFN antagonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Inflammatory responses in Ebola virus-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Human asymptomatic Ebola infection and strong inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Pathogenesis of Ebola hemorrhagic fever in primate models: evidence that hemorrhage is not a direct effect of virus-induced cytolysis of endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Effects of Ebola virus glycoproteins on endothelial cell activation and barrier function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Mechanisms underlying coagulation abnormalities in ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes/macrophages is a key event

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Pathogenesis of experimental Ebola virus infection in guinea pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Haematological, biochemical and coagulation changes in mice, guinea-pigs and monkeys infected with a mouse-adapted variant of Ebola Zaire virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Pathogenesis of experimental Ebola Zaire virus infection in BALB/c mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Evaluation in nonhuman primates of vaccines against Ebola virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Pre- and postexposure prophylaxis of Ebola virus infection in an animal model by passive transfer of a neutralizing human antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Development of human monoclonal antibodies against diseases caused by emerging and biodefense-related viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Evaluation of immune globulin and recombinant interferon-alpha2b for treatment of experimental Ebola virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Recombinant human monoclonal antibodies to Ebola virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Identification of protective epitopes on ebola virus glycoprotein at the single amino acid level by using recombinant vesicular stomatitis viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Ebola virus glycoprotein: proteolytic processing, acylation, cell tropism, and detection of neutralizing antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

A system for functional analysis of Ebola virus glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Glycodendritic structures: promising new antiviral drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

In vitro evaluation of cyanovirin-N antiviral activity, by use of lentiviral vectors pseudotyped with filovirus envelope glycoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

The highly specific carbohydrate-binding protein cyanovirin-N: structure, anti-HIV/Ebola activity and possibilities for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Cyanovirin-N binds to the viral surface glycoprotein, GP1,2 and inhibits infectivity of Ebola virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Functional importance of the coiled-coil of the Ebola virus glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Processing of viral glycoproteins by the subtilisin-like endoprotease furin and its inhibition by specific peptidylchloroalkylketones

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Furin at the cutting edge: from protein traffic to embryogenesis and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Reverse genetics demonstrates that proteolytic processing of the Ebola virus glycoprotein is not essential for replication in cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Interferon, ribavirin, 6-azauridine and glycyrrhizin: antiviral compounds active against pathogenic flaviviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Prospects for treatment of viral hemorrhagic fevers with ribavirin, a broad-spectrum antiviral drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Experimental study on the possibility of treatment of some hemorrhagic fevers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

John Montgomery's legacy: carbocyclic adenosine analogues as SAH hydrolase inhibitors with broad-spectrum antiviral activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Adenosine analogs inhibit the guanine-7-methylation of mRNA cap structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Antiviral drug therapy of filovirus infections: S-adenosylhomocysteine hydrolase inhibitors inhibit Ebola virus in vitro and in a lethal mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Treatment of lethal Ebola virus infection in mice with a single dose of an S-adenosyl-L-homocysteine hydrolase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

3-deazaneplanocin A induces massively increased interferon-alpha production in Ebola virus-infected mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Intracellular phosphorylation of carbocyclic 3-deazaadenosine, an anti-Ebola virus agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Experimental therapy of filovirus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Inhibition of Rous sarcoma viral RNA translation by a specific oligodeoxyribonucleotide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Control of nonsegmented negative-strand RNA virus replication by siRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Inhibition of Marburg virus protein expression and viral release by RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Postexposure protection of guinea pigs against a lethal ebola virus challenge is conferred by RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Resistance of morpholino phosphorodiamidate oligomers to enzymatic degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Morpholino antisense oligomers: the case for an RNase H-independent structural type

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Morpholino antisense oligomers: design, preparation, and properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Inhibition of flavivirus infections by antisense oligomers specifically suppressing viral translation and RNA replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

VP35 knockdown inhibits Ebola virus amplification and protects against lethal infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Gene-specific countermeasures against Ebola virus based on antisense phosphorodiamidate morpholino oligomers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Oligomerization of Ebola virus VP30 is essential for viral transcription and can be inhibited by a synthetic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Late budding domains and host proteins in enveloped virus release

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Ebola virus VP40 late domains are not essential for viral replication in cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

A C-terminal basic amino acid motif of Zaire ebolavirus VP35 is essential for type I interferon antagonism and displays high identity with the RNA-binding domain of another interferon antagonist, the NS1 protein of influenza A virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Emerging roles of tissue factor in viral hemorrhagic fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Development of a preventive vaccine for Ebola virus infection in primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

RNA polymerase I-driven minigenome system for Ebola viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Generation of eGFP expressing recombinant Zaire ebolavirus for analysis of early pathogenesis events and high-throughput antiviral drug screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

Recovery of infectious Ebola virus from complementary DNA: RNA editing of the GP gene and viral cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1523

10.1517/13543784.15.12.1523

21 January 2018

Identifiers

DOI

1 reference

11 June 2017

1 reference